Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography.
暂无分享，去创建一个
R. Boellaard | M. Hellmich | Roman K. Thomas | T. Zander | A. Lammertsma | Y. Ko | E. Smit | W. Engel-Riedel | E. Stoelben | J. Wolf | M. Hallek | A. Jacobs | R. Buettner | M. Dietlein | B. Neumaier | C. Kobe | M. Scheffler | R. Ullrich | L. Heukamp | S. Querings | L. Nogova | K. Toepelt | A. Schlesinger | A. Draube | K. Schulte | I. Papachristou | W. Engel‐Riedel